Article
Direct-acting antiviral therapy for hepatitis C: The initial experience of the University of Cape Town/Groote Schuur Hospital Liver Clinic, South Africa.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde - 29 Jan 2020
Sonderup M W, Gogela N, Nordien R, Smuts H, Korsman S, Hardie D, Spearman C W
Abstract excerpt
BACKGROUND: An estimated 600 000 South Africans are chronically infected with hepatitis C virus (HCV). To date, accurate prevalence data are lacking, but emerging data suggest a significant burden in key populations. Historically, pegylated interferon and ribavirin treatment was challenging, with access limited. The advent of all-oral, short-course direct-acting antiviral (DAA) therapy has revolutionised the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.